Beijing Tiantan Biological Products Corp. Ltd. A | Ownership
Companies that own Beijing Tiantan Biological Products Corp. Ltd. A
Guotai Junan Allianz Fund Management Co., Ltd.
14,601,600
1.68%
0
2.48%
09/30/2017
China Investment Corp. (Investment Management)
13,063,193
1.5%
0
0.1%
09/30/2017
China Universal Asset Management Co., Ltd.
6,747,159
0.78%
-850,302
0.16%
09/30/2017
China Southern Asset Management Co., Ltd.
2,080,058
0.24%
-62,613
0.05%
12/31/2017
Guotai Asset Management Co., Ltd.
1,335,529
0.15%
-476,438
0.06%
12/31/2017
AEGON-INDUSTRIAL Fund Management Co., Ltd.
1,313,638
0.15%
1,313,638
0.06%
12/31/2017
China Merchants Fund Management Co., Ltd.
733,666
0.08%
-1,151,718
0.05%
12/31/2017
The Vanguard Group, Inc.
462,926
0.05%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
454,659
0.05%
31,832
0.02%
12/31/2017
Penghua Fund Management Co., Ltd.
381,585
0.04%
279,960
0.01%
12/31/2017
About Beijing Tiantan Biological Products Corp.
View Profile
| Address |
No.4 Sanjianfang South Li
Beijing Beijing 100024
China
|
|
Employees
|
- |
| Website |
http://www.tiantanbio.com |
| Updated |
07/08/2019 |
| Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production, and sale of biological products. It offers blood albumin; intravenous, hepatitis B and tetanus immunoglobulin; coagulation factors; and protease inhibitors. The company was founded on June 8, 1998 and is headquartered in Beijing, China. |
